David A Maness, 66578 Chimney Bluff Dr, Mount Pleasant, SC 29464

2022026, Aug 25, 2022

Mar 3, 2022

17/653354

- Kalamazoo MI, US
David A. Maness - Mt. Pleasant SC, US

Stryker Corporation - Kalamazoo MI

B09B 3/00
A61B 90/98
A61B 50/39
A61J 1/00
A61B 50/36
A61J 1/14
B65D 81/26
A61B 50/37
A61B 17/00
A61B 50/00
A61B 50/20

An assembly for receiving fluid pharmaceutical waste into a fluid waste receiver includes a fluid receiver body coupled to a fluid receiver cap, and receiving solid pharmaceutical waste into a solid waste receiver includes a solid receiver body coupled to a solid receiver cap. The assembly comprises a receiver housing and a receiver lid coupled to the receiver housing. The receiver housing comprises a retainer base, sidewalls extending from the retainer base, and dividers extending from the sidewalls to divide an interior of the receiver housing into a receiver compartment configured to receive the fluid receiver body and the solid receiver body, and a cap compartment. A first of the dividers divides the receiver compartment from a first of the cap compartments configured to receive the fluid receiver cap, and a second one of the dividers divides the receiver compartment from a second of the cap compartments configured to receive the solid receiver cap.

2021015, May 27, 2021

Feb 3, 2021

17/166091

- Kalamazoo MI, US
David A. Maness - Mt. Pleasant SC, US
Bryan Matthew Ulmer - Grand Rapids MI, US
Dennis Meyer - Augusta MI, US
Lucas Wade - Austin TX, US
Stephen Myers - Austin TX, US
Logan Castillo - Georgetown TX, US
Heather Benoit - Austin TX, US

Stryker Corporation - Kalamazoo MI

B09B 3/00
A61B 50/37
A61B 50/39
A61M 5/32
A61B 50/36
A62D 3/30
B09B 1/00
B65F 1/16

A waste disposal system with a waste receiver for receiving pharmaceutical waste material. A locking assembly is secured to a fixed surface and actuated from a locked configuration to an unlocked configuration. A lock cylinder of the locking assembly may extend forward of a front wall of a receiver body of the waste receiver to engage a locking feature of the cover in the locked configuration. A cover retention feature may prevent axial decoupling of the cover from the receiver body. An engagement feature is moved to be disengaged from the receiver body, and the receiver body is moved away from the fixed surface to disengage the locking assembly from the cover. The cover is decoupled from the cover retention feature, and coupled with the receiver body to seal the pharmaceutical waste material. The locking assembly may be removed from a lock passageway for disposal of the waste receiver.

2020024, Aug 6, 2020

Apr 24, 2020

16/857829

- Kalamazoo MI, US
David A. Maness - Mt. Pleasant SC, US

Stryker Corporation - Kalamazoo MI

B09B 3/00
A61B 50/39
A61B 50/36
A61B 50/37
A61B 90/98
A61J 1/14
B65D 81/26
A61J 1/00

A pharmaceutical waste disposal assembly () for disposing of raw pharmaceutical waste comprises a first receiver body () and a first reaction agent (). The first receiver body () receives the pharmaceutical waste. The first receiver body () includes a receiver bottom (). The first reaction agent () is positioned within the first receiver body () and spaced apart from the receiver bottom (). The pharmaceutical waste reacts with the first reaction agent () to change the pharmaceutical waste in one of a chemical and physical manner so that the pharmaceutical waste is unrecoverable. The first receiver body () can receive fluid pharmaceutical waste and/or solid pharmaceutical waste. The first reaction agent () may include one or more of a denaturant, an emetic and a bittering agent. For example, the first reaction agent () may include one or more of quinine, ipecac and denatonium benzoate.

2019008, Mar 21, 2019

Sep 17, 2018

16/132636

- Kalamazoo MI, US
David A. Maness - Mt. Pleasant SC, US

Stryker Corporation - Kalamazoo MI

B09B 3/00
A61J 1/00
A61B 90/98
B65D 81/26
A61J 1/14
A61B 50/39
G06F 19/00
A61B 50/36
A61B 50/37
A61B 50/00
A61B 17/00
A61B 50/20

A pharmaceutical waste disposal assembly () for disposing of raw pharmaceutical waste includes a first receiver body and a second receiver body. The assembly further includes a first reaction agent and a second reaction agent. The first reaction agent and the second reaction agent renders the pharmaceutical waste unrecoverable. The first reaction agent can include at least one of a denaturant and a deterrent. Additionally, the first reaction agent can include activated charcoal.

2016032, Nov 10, 2016

Jul 19, 2016

15/213950

- Charleston SC, US
David A. Maness - Mt. Pleasant SC, US

B09B 3/00
A61J 1/00

A pharmaceutical waste disposal assembly () for disposing of raw pharmaceutical waste includes a receiver body () and a first reaction agent (). The receiver body () is configured to receive the pharmaceutical waste. The receiver body () includes a body interior wall (A) that defines a body interior (B). The first reaction agent () is positioned within the body interior (B) so that the first reaction agent () contacts the body interior wall (A) prior to receiving the pharmaceutical waste. The first reaction agent () chemically reacts with the pharmaceutical waste so that the pharmaceutical waste is rendered unrecoverable. The first reaction agent () can include at least one of a denaturant and a deterrent. Additionally, the first reaction agent () can include activated charcoal.

2014019, Jul 10, 2014

Mar 10, 2014

14/203408

- Charleston SC, US
David A. Maness - Mt. Pleasant SC, US

Cactus, LLC - Charleston SC

A61J 1/14
B65D 81/26

206204

A pharmaceutical waste disposal assembly () for disposing of fluid pharmaceutical waste comprises a fluid receiver body () and a fluid absorber (A). The fluid receiver body () receives the fluid pharmaceutical waste. The fluid absorber (A) is positioned within the fluid receiver body (). The fluid absorber (A) absorbs and retains the fluid pharmaceutical waste. The fluid absorber (A) includes a plurality of levels (L, M, U) that are spaced apart from one another. The plurality of levels (L, M, U) can be oriented substantially vertically relative to one another so that the fluid pharmaceutical waste is distributed to each of the plurality of levels (L, M, U) of the fluid absorber (A).

2014000, Jan 9, 2014

Aug 14, 2013

13/967117

- Charleston SC, US
David A. Maness - Mt. Pleasant SC, US

Cactus, LLC - Charleston SC

B09B 3/00

2064591

A pharmaceutical waste disposal assembly () comprises a waste receiver () that receives pharmaceutical waste, the waste receiver () including a radio frequency identification tag () that is configured to transmit a radio frequency signal that identifies the waste receiver (). The pharmaceutical waste disposal assembly () can further comprise a receiver retainer () that selectively receives the waste receiver (). The radio frequency identification tag () is configured to transmit the radio frequency signal that is usable to track a location of the waste receiver () regardless of whether or not the waste receiver () is positioned within the receiver retainer (). The receiver retainer () can include an identification reader () that reads the radio frequency signal and is configured to store information from the radio frequency signal that inhibits use of the waste receiver () following removal from and repositioning into the receiver retainer ().

2012030, Dec 6, 2012

Aug 16, 2012

13/587656

David A. Maness - Mt. Pleasant SC, US

B65B 3/00

141 69

A pharmaceutical waste disposal assembly () for disposing of raw pharmaceutical waste comprises a first receiver body () and a first reaction agent (). The first receiver body () receives the pharmaceutical waste. The first receiver body () includes a receiver bottom (). The first reaction agent () is positioned within the first receiver body () and spaced apart from the receiver bottom (). The pharmaceutical waste reacts with the first reaction agent () to change the pharmaceutical waste in one of a chemical and physical manner so that the pharmaceutical waste is unrecoverable. The first receiver body () can receive fluid pharmaceutical waste and/or solid pharmaceutical waste. The first reaction agent () may include one or more of a denaturant, an emetic and a tittering agent. For example, the first reaction agent () may include one or more of quinine, ipecac and denatonium benzoate.